Summit Financial’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$462K Buy
6,806
+642
+10% +$47K 0.01% 1126
2026
Q1
$474K Buy
+6,164
New +$444K 0.01% 1019
2025
Q2
Sell
-2,504
Closed -$221K 818
2025
Q1
$221K Buy
2,504
+40
+2% +$3.78K 0.01% 675
2024
Q4
$227K Buy
+2,464
New +$253K 0.01% 593
2024
Q3
Sell
-2,160
Closed -$213K 544
2024
Q2
$213K Buy
+2,160
New +$214K 0.01% 469
2022
Q1
Sell
-1,659
Closed -$202K 251
2021
Q4
$202K Buy
+1,659
New +$184K 0.02% 239

Other funds holding EMN

Summit Financial's EMN Position: Q2 2026 in Review

Summit Financial increased its Eastman Chemical (EMN) stake by 10% in Q2 2026, buying an estimated $47K and bringing the position to 6,806 shares worth $462K. The position accounts for 0.01% of the portfolio, ranked #1126.

Summit Financial first reported a position in EMN in Q4 2021 and has held it in 6 quarters since. The position peaked at $474K in Q1 2026. 646 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Summit Financial held 6,806 shares of Eastman Chemical worth $462K as of Q2 2026.
  • Summit Financial bought 642 Eastman Chemical shares in Q2 2026, an estimated $47K.
  • Eastman Chemical made up 0.01% of Summit Financial's portfolio in Q2 2026, its #1126 holding.
  • Summit Financial first reported a position in Eastman Chemical in Q4 2021 and has held it in 6 quarters since.
  • Summit Financial's Eastman Chemical position peaked at $474K in Q1 2026.
  • 646 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.